Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             193 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A controlled trial comparing budesonide with mesalazine for the treatment of active Crohn disease Copaci, I.
2000
32 S1 p. A23-
1 p.
artikel
2 Activin a modulates intestinal epithelial cell function in vitro Jung, S.
2000
32 S1 p. A19-
1 p.
artikel
3 Additional evidence for an inflammatory bowel disease (IBD) locus on 14q11–12 Vermeire, S.
2000
32 S1 p. A49-
1 p.
artikel
4 Anastomotic configuration and recurrence of ileocolonic Crohn's disease Alessandroni, L.
2000
32 S1 p. A36-
1 p.
artikel
5 Ankylosing spondylitis in ulcerative colitis Krstic, M.
2000
32 S1 p. A49-
1 p.
artikel
6 A novel role for the neuropeptide neurotensin in chronic colitis Cataldi, F.
2000
32 S1 p. A34-
1 p.
artikel
7 Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes apoptosis in experimental murine colitis Ito, H.
2000
32 S1 p. A28-
1 p.
artikel
8 Anti-P53 serum antibodies: A new strategy for improving colorectal cancer surveillance in ulcerative colitis Riegler, G.
2000
32 S1 p. A12-
1 p.
artikel
9 Anti-saccharomyces cerevisiae mannan (ASCA) antibodies in inflamatory bowel disease (IBD) Annese, V.
2000
32 S1 p. A6-
1 p.
artikel
10 Apoptosis in colon of rat with induced colitis Della Valle, N.
2000
32 S1 p. A41-
1 p.
artikel
11 A rare association between inflammatory bowel disease (IBD), coeliac disease, membranous glomerulonephritis and leg venous thrombosis associated to heterozygosis for V Leiden factor Casella, Giovanni
2000
32 S1 p. A44-
1 p.
artikel
12 ASCA detection in an Italian IBD population: Preliminary results Daperno, M.
2000
32 S1 p. A14-
1 p.
artikel
13 Author index 2000
32 S1 p. A53-A57
nvt p.
artikel
14 Azathioprine metabolite levels: A therapeutic index of clinical efficacy in IBD Cuffari, C.
2000
32 S1 p. A52-
1 p.
artikel
15 Bacteria in pouch tissue Helwig, U.
2000
32 S1 p. A38-
1 p.
artikel
16 B2-microglobulin plasma level in remission as a prognostic test of the severity of relapse in ulcerative colitis Mishurovskaja, T.
2000
32 S1 p. A25-
1 p.
artikel
17 Bowel ultrsonography in detecting bowel stenosis in inflammatory bowel diseases Mijalkovic, N.
2000
32 S1 p. A46-
1 p.
artikel
18 Budesonide in the treatment of Crohn's disease. A meta-analysis Papi, C.
2000
32 S1 p. A11-
1 p.
artikel
19 Budesonide is superior to mesalazine in maintaining disease remission for patients with steroid-dependent Crohn's disease Mantzaris, G.J.
2000
32 S1 p. A29-
1 p.
artikel
20 Cancer in the anal canal after handsewn ileoanal anastomosis, report of a case Laureti, S.
2000
32 S1 p. A38-
1 p.
artikel
21 Carnitine levels in colon, muscle and serum of rats with experimental colitis Cosenza, V.
2000
32 S1 p. A9-
1 p.
artikel
22 CD2-mediated activation of stat: Transactivation of the IFN-γ intronic stat cis-element is unique for LPMC and independent of IL-12 Gonsky, R.
2000
32 S1 p. A27-
1 p.
artikel
23 Changing patterns in pediatric-onset Crohn's disease: A 30 year epidemiologic study Critch, J.N.
2000
32 S1 p. A21-
1 p.
artikel
24 Characterization of single nucleotide polymorphism (SNP) haplotypes of IL4 receptor α gene in inflammatory bowel disease Zhang, W.J.
2000
32 S1 p. A21-
1 p.
artikel
25 Chemokine expression in pouchitis Lammers, K.M.
2000
32 S1 p. A39-
1 p.
artikel
26 Cholestyramine's ability to bind intestinal bacterial products: potential role in IBD Christian, Aimee E.
2000
32 S1 p. A50-
1 p.
artikel
27 Clinical and endoscopic characteristics of indeterminate colitis as predictive signs of the definitive diagnosis Pica, R.
2000
32 S1 p. A14-
1 p.
artikel
28 Clinical course of familial and sporadic cases of Crohn's disease Orlando, A.
2000
32 S1 p. A13-
1 p.
artikel
29 Colitis mimicking Crohn's disease in patient with rheumatoid arthritis Pirrelli, M.
2000
32 S1 p. A13-
1 p.
artikel
30 Comparison of oral versus combination mesalazine therapy in active ulcerative colitis: A duble-blind, double-dummy, randomized, multi-center Italian study Vecchi, M.
2000
32 S1 p. A36-
1 p.
artikel
31 Complementary therapy in IBD patients: Who uses it and why? Rampton, D.S.
2000
32 S1 p. A33-
1 p.
artikel
32 Connective tissue changes in ileal Crohn's disease; relationship to disease phenotype and ulcer associated cell lineage Borley, N.R.
2000
32 S1 p. A22-
1 p.
artikel
33 Correlation between disease knowledge and quality of life in IBD patients Niemer, Sally
2000
32 S1 p. A23-
1 p.
artikel
34 Correlations between inflammatory bowel disease and colonic cancer in Romania Bataga, S.
2000
32 S1 p. A49-
1 p.
artikel
35 Crohn's disease of the upper intestinal tract Luetke, A.
2000
32 S1 p. A18-
1 p.
artikel
36 Diagnosis of fistulas in Crohn's disease with power doppler sonography (PDUS) Maconi, G.
2000
32 S1 p. A37-
1 p.
artikel
37 Different strictureplasty options to avoid resections in complicated Crohn's disease Danelli, P.G.
2000
32 S1 p. A33-
1 p.
artikel
38 Discordant sibling pair linkage analysis provides further support for the chromosome 12 inflammatory bowel disease susceptibility locus van Heel, D.A.
2000
32 S1 p. A19-
1 p.
artikel
39 Distinct cytokine patterns differentiate early vs. late colitis in IL-10-deficient mice Spencer, D.M.
2000
32 S1 p. A21-
1 p.
artikel
40 Distinctive patterns of inflammatory response in microscopic colitis compared with resolving Campylobacter enteritis Jenkins, D.
2000
32 S1 p. A31-
1 p.
artikel
41 DNA aneuploidy in long-standing ulcerative colitis D'Albasio, G.
2000
32 S1 p. A7-
1 p.
artikel
42 Does close rectal dissection for proctectomy in inflammatory bowel disease protect against impotence? Lindsey, I.
2000
32 S1 p. A19-
1 p.
artikel
43 Does the full remission of ulcerative colitis exist? Belousova, E.
2000
32 S1 p. A27-
1 p.
artikel
44 E-cadherin expression in Crohn's disease Di Sabatino, A.
2000
32 S1 p. A39-
1 p.
artikel
45 Echodoppler of the inferior mesenteric artery in monitoring response to therapy in patients suffering from acute ulceratibe colitis Giannetti, A.
2000
32 S1 p. A43-
1 p.
artikel
46 Effectiveness evaluation of 3 probiotics from different strains of lactobacilli under clinical conditions Lizko, N.
2000
32 S1 p. A24-
1 p.
artikel
47 Epidermal growth factor receptor is associated with evidence of smooth muscle proliferation in Crohn's disease ulcers Borley, N.R.
2000
32 S1 p. A22-
1 p.
artikel
48 Epithelial and lymphocyte apoptosis in Crohn's disease (CD) Di Sabatino, A.
2000
32 S1 p. A42-
1 p.
artikel
49 Epithelial proliferation and ras p21 oncoprotein in the rectum of patients with ulcerative colitis Ierardi, E.
2000
32 S1 p. A5-
1 p.
artikel
50 Epithelial regeneration is dysregulated in SAMP1/YIT mice, a spontaneous model of Crohn's disease Tustison, K.
2000
32 S1 p. A15-
1 p.
artikel
51 ERBB-1 expression in experimental model of inflammatory bowel disease in rats Trzcinski, R.
2000
32 S1 p. A51-
1 p.
artikel
52 Etanercept (TNF receptor fusion protein, enbrel®) is effective and well tolerated in active refractory Crohn's disease: Results of a single center pilot trial D'Haens, G.
2000
32 S1 p. A42-
1 p.
artikel
53 Evaluation of the tumor necrosis factor (TNF) family of inhibitors in the dextran sulfate model of mouse colitis Murthy, S.
2000
32 S1 p. A20-
1 p.
artikel
54 Evolution of microscopic features of ulcerative colitis during follow-up Ambu, R.
2000
32 S1 p. A18-
1 p.
artikel
55 Experimental colitis increases small bowel permeability to sugar probes in the Wistar-Kyoto (WKY) rat Giofré, M.R.
2000
32 S1 p. A10-
1 p.
artikel
56 Expression of B7 costimulatory molecules in experimental inflammatory bowel disease Howarth, G.S.
2000
32 S1 p. A30-
1 p.
artikel
57 Extracolonic manifestation of the ulcerative colitis: pyoderma gangrenosum Paszkowski, J.
2000
32 S1 p. A16-
1 p.
artikel
58 Factor V Leiden and prothrombin gene mutation in inflammatory bowel disease in a Mediterranean area Rosselli, M.
2000
32 S1 p. A10-
1 p.
artikel
59 Faecal sIgA in the evaluation of integrity of mucosa systems of defence Vikha, G.
2000
32 S1 p. A45-
1 p.
artikel
60 Family history of colorectal cancer is a risk factor for early-onset colorectal cancer in inflammatory bowel disease Askling, J.
2000
32 S1 p. A24-
1 p.
artikel
61 Fibrosing colonopathy associated with mesalazine treatment in adult patient Sambataro, A.
2000
32 S1 p. A43-
1 p.
artikel
62 Focally enhanced gastritis could be patognomonic for Crohn's disease Lecis, P.E.
2000
32 S1 p. A42-
1 p.
artikel
63 Gallstone and Crohn's disease. Results from a large cohort Losco, A.
2000
32 S1 p. A42-
1 p.
artikel
64 Genetic and inflammatory bowel disease(IBD): is there a relationship between polymorphisms of hMLH1 gene and different subtype of ulcerative colitis (UC)? Tarantino, O.
2000
32 S1 p. A15-
1 p.
artikel
65 Gut pH and transit time in ulcerative colitis appear sufficient for complete dissolution of pH-dependent 5-ASA-containing capsules Nugent, S.G.
2000
32 S1 p. A45-
1 p.
artikel
66 Healing of perianal fistulae by local injection of antibody to TNFα Simon Lichtiger M.D. Mount Sinai Medical Center New York 2000
32 S1 p. A5-
1 p.
artikel
67 Helminthic parasite exposure protects mice from colitis Elliott, D.
2000
32 S1 p. A26-
1 p.
artikel
68 Heme oxygenase-1 (HO-1) induction in human intestinal epithelial cells by sulphasalazine, 5-aminosalicyclic acid and bismuth citrate: A novel potential therapeutic mechanism Cavicchi, M.
2000
32 S1 p. A23-
1 p.
artikel
69 Herbal therapies used by patients for inflammatory bowel disease are antioxidant in vitro Langmead, L.
2000
32 S1 p. A48-
1 p.
artikel
70 High-density genome scan in Crohn's disease shows linkage to chromosome 14Q and linkage and association with chromosome 3P Duerr, R.H.
2000
32 S1 p. A27-
1 p.
artikel
71 Highly concentrated probiotics prevent pouchitis onset Amadini, C.
2000
32 S1 p. A12-
1 p.
artikel
72 HLA-dependent and HLA-independent forms of ulcerative colitis (UC) in Russia Morozova, N.
2000
32 S1 p. A27-
1 p.
artikel
73 HLA-DRB1 gene may be the specific genetic marker in patients with distal ulcerative colitis Khalif, I.L.
2000
32 S1 p. A35-
1 p.
artikel
74 Identification of two novel susceptibility loci in a Canadian inflammatory bowel disease population Rioux, J.D.
2000
32 S1 p. A20-
1 p.
artikel
75 Ileal adenocarcinoma: Intraoperatory evidence at first diagnosis of Crohn's disease Demarchi, B.
2000
32 S1 p. A7-
1 p.
artikel
76 Ileo-colonic inflammation in spondyloarthropathies (SpA) of childhood Franco, M.T.
2000
32 S1 p. A40-
1 p.
artikel
77 Immunohystochemical study of nitric oxide synthase's (NOS) activity in IBD colonic mucosa Palatka, K.
2000
32 S1 p. A20-
1 p.
artikel
78 Immunostimulatory DNA sequences ameliorate experimental colitis in mice and rats Rachmilewitz, D.
2000
32 S1 p. A31-
1 p.
artikel
79 Impact of inflammatory bowel disease on patient genital life Fekih, M.
2000
32 S1 p. A50-
1 p.
artikel
80 Inactive tissue transglutaminase in rats with experimental colitis D'Argenio, G.
2000
32 S1 p. A8-
1 p.
artikel
81 Incidence and treatment for intestinal obstruction after ileoanal anastomosis Ugolini, F.
2000
32 S1 p. A38-
1 p.
artikel
82 Incidence and treatment for late perianal fistula after ileoanal anastomosis Laureti, S.
2000
32 S1 p. A15-
1 p.
artikel
83 Indeterminate colitis and other relative controindications to restorative proctocolectomy: Immediate and long-term results Montesani, C.
2000
32 S1 p. A52-
1 p.
artikel
84 Indeterminate colitis (IC) in IBD patients in Moscow Region (Russia) Zlatkina, A.R.
2000
32 S1 p. A47-
1 p.
artikel
85 Inflammation-induced impairment of cholinergic nerve function is mediated by macrophage-colony stimulating factor-dependent macrophages Galeazzi, F.
2000
32 S1 p. A32-
1 p.
artikel
86 Inflammatory bowel disease (IBD) in children five years of age and younger; a diagnostic dilemma Mamula, Petar
2000
32 S1 p. A51-
1 p.
artikel
87 Inflammatory bowel diseeses are associated with the DNA repair gene MLH Annese, V.
2000
32 S1 p. A6-
1 p.
artikel
88 Infliximab binds human monocytes but not mucosal T cells in vitro: No direct anti-T cell mechanism of action Kugathasan, S.
2000
32 S1 p. A45-
1 p.
artikel
89 Infliximab therapy in 100 Crohn's disease patients: Clinical efficacy and adverse events Farrell, R.J.
2000
32 S1 p. A16-
1 p.
artikel
90 Inherited thrombophilia in inflammatory bowel disease Papa, A.
2000
32 S1 p. A36-
1 p.
artikel
91 Inhibition of inducible nitric oxide synthase (iNOS) by bismuth preparations and sulphasalasine in human intestinal epithelial cells Whittle, B.J.R.
2000
32 S1 p. A23-
1 p.
artikel
92 Interleukin-18 as a marker for disease specificity and severity in patients with IBD Makipour, K.
2000
32 S1 p. A25-
1 p.
artikel
93 Interleukin-12 receptor β2, a crucial component in the IL-12 TH1 response, is up-regulated in Crohn's disease Parrello, T.
2000
32 S1 p. A52-
1 p.
artikel
94 Kinetics of ASCA: A time-related study in a Belgian CD population Joossens, S.
2000
32 S1 p. A46-
1 p.
artikel
95 Lack of activation of plasma contact system in Crohn's disease: A possible role of increased C1-inhibitor levels Devani, M.
2000
32 S1 p. A37-
1 p.
artikel
96 Lactobacterine in prevention of the acute intestinal infections of flying personnel Belakovsky, M.
2000
32 S1 p. A24-
1 p.
artikel
97 Laparoscopically-assisted ileocolonic resection for Crohn's disease Alessandroni, L.
2000
32 S1 p. A36-
1 p.
artikel
98 “Late onset” idiopathic pancreatitis in childre with ulcerative colitis : case report Romano, C.
2000
32 S1 p. A44-
1 p.
artikel
99 Linkage to IBD1 locus does not identify specific clinical phenotypes in familial IBD patients Annese, V.
2000
32 S1 p. A6-
1 p.
artikel
100 Lipid profile in patients with Crohn's disease: Relationship with disease localisation and metabolic variables Capristo, E.
2000
32 S1 p. A39-
1 p.
artikel
101 Long-term impact of Crohn's disease (CD) pharmacotherapy: Treat registry baseline results Sandborn, W.
2000
32 S1 p. A40-
1 p.
artikel
102 Low dosage of intravenous cyclosporine in the treatment of severe ulcerative colitis Rosselli, M.
2000
32 S1 p. A9-
1 p.
artikel
103 Macrophages do not contribute to dextran-sulfate induced colitis Ford, D.
2000
32 S1 p. A32-
1 p.
artikel
104 Maintenance of remission of ulcerative colitis (UC): Mesalamine, dietary fiber, S. Boulardi Copaci, I.
2000
32 S1 p. A24-
1 p.
artikel
105 Markovian features in longstanding ulcerative colitis Armentano, R.
2000
32 S1 p. A13-
1 p.
artikel
106 May a failure of the therapy with anti-TNFα (infliximab) reveal a misdiagnosis of Crohn's disease? Ierardi, E.
2000
32 S1 p. A5-
1 p.
artikel
107 Meeting calendar 2000
32 S1 p. A1-A4
nvt p.
artikel
108 Metronidazole treatment of bacterial overgrowth in patients with Crohn's disease: Assessment by hydrogen/methane lactulose breath test Castiglione, G.
2000
32 S1 p. A51-
1 p.
artikel
109 Modulation in the expression of intestinal MUC3 mucin by non-pathogenic probiotic microbes Mack, D.R.
2000
32 S1 p. A29-
1 p.
artikel
110 Mucosal integrity and apoptosis: Efficient and rapid execution of programmed cell death in primary human intestinal epithelial cells which die of apoptosis as they reach the intestinal lumen Grossmann, J.
2000
32 S1 p. A16-
1 p.
artikel
111 NK-1R and NK-2R gene and protein expression in Crohn's disease (CD) and ulcerative colitis (UC) Renzi, D.
2000
32 S1 p. A8-
1 p.
artikel
112 N-L-glutamyl-UDCA as prodrug for colon-specific drug delivery Clerici, Carlo
2000
32 S1 p. A11-
1 p.
artikel
113 Nominal evidence for linkage to chromosome 3p21 in Finnish IBD families: No association with chemokine receptor, CCR5 Paavola, P.
2000
32 S1 p. A14-
1 p.
artikel
114 Normalization of bowel wall after strictureplasty and miniresection for complicated Crohn's disease Sampietro, G.M.
2000
32 S1 p. A34-
1 p.
artikel
115 Open labeled pilot study of thalidomide (THAL) as a novel therapy for medically resistant ulcerative colitis (UC) Kam, L.Y.
2000
32 S1 p. A48-
1 p.
artikel
116 Oral 5-ASA is protective against proximal extention of the mucosomal inflammation in ulcerative proctitis Pica, R.
2000
32 S1 p. A41-
1 p.
artikel
117 Osteopenia is frequent in children with Crohn's disease at diagnosis Griffiths, A.M.
2000
32 S1 p. A17-
1 p.
artikel
118 Our experience in restorative proctocolectomy and s-pouch procedure for ulcerative colitis Montecamozzo, G.
2000
32 S1 p. A34-
1 p.
artikel
119 Oxidant stress has specific and potent effects on the expression of collagen and collagenase by human intestinal smooth muscle (HISM) cells Graham, M.
2000
32 S1 p. A22-
1 p.
artikel
120 Oxidative DNA damage in ulcerative colitis D'Incà, R.
2000
32 S1 p. A12-
1 p.
artikel
121 Paediatric inflammatory bowel disease in Tuscany, Italy Lionetti, P.
2000
32 S1 p. A13-
1 p.
artikel
122 Perinuclear anti-neutrophil cytoplasmatic antibodies (p-ANCA) and anti-saccharomyces cerevisiae antibodies (ASCA) assays in the diagnosis of inflammatory bowel disease (IBD) Vecchi, M.
2000
32 S1 p. A37-
1 p.
artikel
123 Persistent need for surgical management of Crohn's fistuli after remicade treatment Koltun, W.A.
2000
32 S1 p. A43-
1 p.
artikel
124 Population differences in allelic associations of the interleukin-1 gene cluster (IL-1B, IL-1 Re and IL-1 Ra), and plasma concentrations of IL-1B and IL-1 Ra in South African patients with inflammatory bowel diseases (IBD) and control individuals Gaillard, M.C.
2000
32 S1 p. A50-
1 p.
artikel
125 Pouch surgery: Outcome in patients with ulcerative colitis Selvaggi, F.
2000
32 S1 p. A9-
1 p.
artikel
126 Prediction of relapse after treatment with infliximab in patients with Crohn's disease by increased peripheral production of TNF-α and mucosal levels of activated NFκB Nikolaus, S.
2000
32 S1 p. A21-
1 p.
artikel
127 Predictive factors of recurrence in Crohn's disease Fekih, M.
2000
32 S1 p. A28-
1 p.
artikel
128 Presentation of colorectal cancer in patients with ulcerative colitis: a GISC-GSMII multicenter investigation Riegler, G.
2000
32 S1 p. A10-
1 p.
artikel
129 Prevalence, clinical, laboratory and immunogenetic aspects of articular manifestations in inflammatory bowel disease (IBD) Ferronato, A.
2000
32 S1 p. A43-
1 p.
artikel
130 Prevalence of cytomegalovirus (CMV) infection in severe refractory IBD colitis Pietrosi, G.
2000
32 S1 p. A9-
1 p.
artikel
131 Prevalence of Helicobacter pylori infection in patients at diagnosis of inflammatory bowel disease (IBD) Pellicano, R.
2000
32 S1 p. A7-
1 p.
artikel
132 Prevention of pancreatitis by weekly amylase assay in patients with Crohn's disease treated with azathioprine Castiglione, F.
2000
32 S1 p. A5-
1 p.
artikel
133 Primary sclerosing cholangitis at the patients operated due to ulcerative colitis Pyda, P.
2000
32 S1 p. A16-
1 p.
artikel
134 Prognostic indicators for complications after surgery in Crohn's disease Bresso, F.
2000
32 S1 p. A7-
1 p.
artikel
135 Prophylaxis of postoperative recurrence of Crohn's disease: Combination of antibiotic and probiotic versus mesalamine Rizzello, F.
2000
32 S1 p. A37-
1 p.
artikel
136 Quality of life evaluation in patients with ulcerative colitis in a randomized clinical trial: Responsiveness and validity of a disease-specific questionnaire Saibeni, S.
2000
32 S1 p. A35-
1 p.
artikel
137 Quote-IBD: The patients' opinion is necessary in quality of care Russel, M.
2000
32 S1 p. A29-
1 p.
artikel
138 Randomized, controlled trial to compare the J and W pouch configurations for ulcerative colitis in the maturation period Selvaggi, F.
2000
32 S1 p. A10-
1 p.
artikel
139 Rapid and prolonged closure of Crohn's disease fistulas with intensified immunosuppressive therapy Engelhardt, E.
2000
32 S1 p. A28-
1 p.
artikel
140 Reduced plasma antioxidants levels and increased oxidative DNA damage in inflammatory bowel diseases Bortolan, S.
2000
32 S1 p. A12-
1 p.
artikel
141 Regional expression of thymus expressed chemokine (TECK) and its receptor CCR9 in the small bowel: Evidence for enhanced recirculation of CCR9+ lymphocytes in small bowel Crohn's disease Papadakis, K.A.
2000
32 S1 p. A44-
1 p.
artikel
142 Regulation of CD4+ T cell functions by lactobacilli von der Weid, T.
2000
32 S1 p. A40-
1 p.
artikel
143 Rehydration measures in patients with a high flow ileostomy or severe diarrhoea — A new promising concept Leif, Hultén
2000
32 S1 p. A30-
1 p.
artikel
144 Relationship between clinical, endoscopy and histology activity index in patients with complicated Crohn's disease Pavlovic, A.
2000
32 S1 p. A46-
1 p.
artikel
145 Resiliency of a model human intestinal epithelium to FAS-mediated apoptotic injury Abreu, M.T.
2000
32 S1 p. A19-
1 p.
artikel
146 Response to azathioprine therapy in Crohn's disease: A logistic regression model Demarchi, B.
2000
32 S1 p. A8-
1 p.
artikel
147 Role of inducible nitric oxide synthase in a spontaneously developing chronic colitis in interleukin-10 deficient mice McCafferty, D.-M.
2000
32 S1 p. A47-
1 p.
artikel
148 Role of leptin and TNF-α in energy metabolism regulation in patients with inflammatory bowel disease Capristo, E.
2000
32 S1 p. A39-
1 p.
artikel
149 Role of occludin in inflammation-induced permeability alterations of the terminal ileum in the rat Fries, W.
2000
32 S1 p. A11-
1 p.
artikel
150 Role of Saccharomyces boulardii in the prevention of clinical relapses of Crohn's disease Guslandi, M.
2000
32 S1 p. A44-
1 p.
artikel
151 Role of the CD40 in the inflammatory bowel diseases (IBD) : Histochemical analysis and clinical correlation Polese, L.
2000
32 S1 p. A41-
1 p.
artikel
152 RXR and PPARγ nuclear receptors exert a synergistic anti-inflammatory effect. Potential role in ulcerative colitis (UC) Desreumaux, P.
2000
32 S1 p. A32-
1 p.
artikel
153 Serum chondrex (YLK-40) in patients with arthritis associated with inflammatory bowel disease (IBD) Ferronato, A.
2000
32 S1 p. A11-
1 p.
artikel
154 Short-term efficacy of chimeric monoclonal antibody cA2 to tumor necrosis factor α for refractory, fistulizing Crohn's disease Bollani, S.
2000
32 S1 p. A34-
1 p.
artikel
155 Side to side isoperistaltic strictureplasty in Crohn disease: Report of two cases Sommariva, A.
2000
32 S1 p. A14-
1 p.
artikel
156 Small bowel permeability (using lactulose/mannitol and lactulose/xylose tests) in patients with Crohn's disease and ulcerative proctocolitis Kohout, P.
2000
32 S1 p. A40-
1 p.
artikel
157 Small intestinal luminal pH in Crohn's disease: Implications for release of antiinflammatory drugs from pH-dependent capsules Nugent, S.G.
2000
32 S1 p. A47-
1 p.
artikel
158 Smoking and inflammatory bowel deseases (IBD) Guglielmi, V.
2000
32 S1 p. A51-
1 p.
artikel
159 Sodium glucose co-transporter activity and gene expression in the human ileum in Crohn's disease Wild, G.E.
2000
32 S1 p. A25-
1 p.
artikel
160 Stapled end-to-side vs sutured side-to-side anastomosis in Crohn's disease Scarpa, M.
2000
32 S1 p. A41-
1 p.
artikel
161 Surgical strategy, complications and long term prognosis of conservative surgery in Crohn's disease Cristaldi, M.
2000
32 S1 p. A35-
1 p.
artikel
162 Survival and multiplication of adherent-invasive E. coli strains isolated from patients with Crohn's disease (CD) in the J774 murine macrophage-like cell line Glasser, A.-L.
2000
32 S1 p. A22-
1 p.
artikel
163 Tarnsabdominal bowel sonography in gastroduodenal Crohn's disease Grbovic, A.
2000
32 S1 p. A45-
1 p.
artikel
164 TGF-β and IL-10 preserve macromolecular transport during IL-4 induced increased permeability in T84 monolayers Di Leo, V.
2000
32 S1 p. A33-
1 p.
artikel
165 The assessment of nutritional state of surgical patients with IBD and its clinical importance Skowroñska-Piekarska, U.
2000
32 S1 p. A17-
1 p.
artikel
166 The blood vessels changes at the patients with ulcerative colitis—the cause or the result of the disease? Banasiewicz, T.
2000
32 S1 p. A17-
1 p.
artikel
167 The CCR5-Δ32 gene mutation is not associated with inflammatory bowel disease Craggs, A.
2000
32 S1 p. A29-
1 p.
artikel
168 The determination of P-ANCA and ASCA could be useful in differentiating Crohn's disease from ulcerative colitis Lecis, P.E.
2000
32 S1 p. A35-
1 p.
artikel
169 The effects of prednisone and budesonide on the activity and expression of the Na+ glucose co-transporter in trinitrobenzene sulfonic acid induced ileitis in the rat Wild, G.E.
2000
32 S1 p. A25-
1 p.
artikel
170 The natural history of fistulizing Crohn's disease: A population-based study Schwartz, D.A.
2000
32 S1 p. A18-
1 p.
artikel
171 The perception of quality of life in inflammatory bowel disease (IBD) mainly depends on disease activity Saibeni, S.
2000
32 S1 p. A33-
1 p.
artikel
172 The risk for dysplasia and neoplasia in the ileal pouch — A controversial issue Hultén, Leif
2000
32 S1 p. A31-
1 p.
artikel
173 The role of follow-up in the management of inflammatory bowel disease Jakab, Zs.
2000
32 S1 p. A20-
1 p.
artikel
174 The role of nicotine in IBD: The severity of experimental colitis in mice is dependent on the presence of the α5 neuronal nicotinic acetylcholine receptor subunit (nAChR) Rachmilewitz, D.
2000
32 S1 p. A31-
1 p.
artikel
175 The T cell substance P receptor is subject to immunoregulation Blum, A.
2000
32 S1 p. A26-
1 p.
artikel
176 The terminal ileum of the rat is responsive to betacellulin administration Howarth, G.S.
2000
32 S1 p. A30-
1 p.
artikel
177 The tissue embrionic antigens depending on the form of ulcerative colitis Nikitina, N.V.
2000
32 S1 p. A47-
1 p.
artikel
178 The TNFα-308∗2 allele predicts non-response to remicade® Vermeire, S.
2000
32 S1 p. A28-
1 p.
artikel
179 The use of alternative medicine practices amongst patients with inflammatory bowel disease Chutkan, R.
2000
32 S1 p. A48-
1 p.
artikel
180 The use of azathioprine in a severe case of steroid dependent ulcerative colitis Abazi, A.
2000
32 S1 p. A50-
1 p.
artikel
181 The use of magnetic resonance imaging and transabdominal bowel sonography in detecting fistulas in Crohn's disease Djuranovic, S.
2000
32 S1 p. A46-
1 p.
artikel
182 Transabdominal ultrasonography in inflammatory bowel diseases and its complications Grbovic, A.
2000
32 S1 p. A48-
1 p.
artikel
183 Treatment of fistulas in Crohn's disease with infliximab anti-tumor necrosis factor antibodies Kohn, A.
2000
32 S1 p. A8-
1 p.
artikel
184 Treatment options and surgical outcome for patients with dysplasia on ulcerative colitis Laureti, S.
2000
32 S1 p. A38-
1 p.
artikel
185 T-regulatory-1 cells prevent colitis induced by enteric bacterial antigen-reactive pathogenic Th1 cells Cong, Y.
2000
32 S1 p. A15-
1 p.
artikel
186 Trichuris suis appears safe and effective in treating inflammatory bowel disease, probably by modifying mucosal TH1/TH2 immune balance Summers, R.W.
2000
32 S1 p. A26-
1 p.
artikel
187 Tr1-like regulatory clones isolated from the lamina propria of DO11.10 transgenic mice inhibit Th1 cells proliferation and ameliorate CD45RBhigh colitis Saparov, Arman
2000
32 S1 p. A49-
1 p.
artikel
188 Tumour necrosis factor haplotype as a risk factor for low bone mass in ulcerative colitis Nemetz, A.
2000
32 S1 p. A32-
1 p.
artikel
189 Two and four mg/kg/day of IV cyclosporine are equally effective in severe attacks of ulcerative colitis D'Haens, G.
2000
32 S1 p. A18-
1 p.
artikel
190 Ulcerative colitis (UC) and Crohn's disease (CD) tissue gene expression profiling by DNA microarray techniques: Diagnostic and therapeutic implications Lawrance, I.C.
2000
32 S1 p. A30-
1 p.
artikel
191 Untoward effect of anti-TNF therapy in Crohn's disease — A case report Annese, V.
2000
32 S1 p. A6-
1 p.
artikel
192 Utilization and charges for pediatric inflammatory bowel disease (IBD) Ferry, G.
2000
32 S1 p. A26-
1 p.
artikel
193 What is the role of glutamine supported AIO parenteral nutrition in surgical severly depleted patients with IBD Skowroñska-Piekarska, U.
2000
32 S1 p. A17-
1 p.
artikel
                             193 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland